Document is current
Any future updates will be listed below
-
Authors
Tropea, Thomas F.
Hartstone, Whitney
Amari, Noor
Baum, Dylan https://orcid.org/0009-0009-6875-9316
Rick, Jacqueline
Suh, Eunran
Zhang, Hanwen
Paul, Rachel A. https://orcid.org/0009-0001-3793-6326
Han, Noah
Zack, Rebecca
Brody, Eliza M. https://orcid.org/0000-0002-6634-0978
Albuja, Isabela
James, Justin https://orcid.org/0000-0003-1799-3603
Spindler, Meredith https://orcid.org/0000-0002-3632-2613
Deik, Andres https://orcid.org/0000-0001-5527-0196
Aamodt, Whitley W. https://orcid.org/0000-0001-8130-2809
Dahodwala, Nabila
Hamedani, Ali
Lasker, Aaron https://orcid.org/0009-0003-4590-138X
Hurtig, Howard
Stern, Matthew
Weintraub, Daniel https://orcid.org/0000-0003-0633-7168
Vaswani, Pavan https://orcid.org/0000-0002-1826-6275
Willis, Allison W.
Siderowf, Andrew https://orcid.org/0000-0002-1750-7698
Xie, Sharon X.
Van Deerlin, Vivianna
Chen-Plotkin, Alice S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS115139, AG072979, AG062418)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS114167)
Penn Center for Precision Medicine, Parker Family Chair at The University of Pennsylvania
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 11 August 2023
Accepted: 19 March 2024
First Online: 3 May 2024
Competing interests
: T.F.T. No relevant disclosures or COIs. T.F.T. has received grants from the NIH (K23-NS114167), and research support from the Parkinson Foundation and The Michael J Fox Foundation. He has received consulting fees and honoraria from Sanofi Genzyme, Bial, and the Parkinson Foundation. W.H. No relevant disclosures or COIs. N.A. No relevant disclosures or COIs. D.B. No relevant disclosures or COIs. J.R. No relevant disclosures or COIs. E.S. No relevant disclosures or COIs. H.Z. No relevant disclosures or COIs. R,A.P. No relevant disclosures or COIs. N.H. No relevant disclosures or COIs. R.Z. No relevant disclosures or COIs. E.M.B. No relevant disclosures or COIs. I.A. No relevant disclosures or COIs. J.J. No relevant disclosures or COIs. M.Sp. No relevant disclosures or COIs. A.D. No relevant disclosures or COIs. A.D. has received clinical trial funding from Teva, Lundbeck, Cerevel, Eli Lilly, and Annovis Bio, royalties from UpToDate and Elsevier and serves on advisory boards for Laboratorios LAM, Supernus, Abbvie. W.A.A. No relevant disclosures or COIs. W.A.A. has received grant from the American Academy of Neurology (CRTS in Neurodisparities). N.D. No relevant disclosures or COIs. N.D. receives grant support from the NIH (R01NS125294, U19AG062418), Michael J Fox Foundation, Parkinson Foundation, Genentech (clinical trial). She has received honoraria from Mediflix and consulting fees from Genentech. She has reviewed medical records for Post & Schell (law firm). A.H. No relevant disclosures or COIs. A.H. has received grants from the National Eye Institute and the Michael J. Fox Foundation and clinical trial support from Biogen and Biohaven. A.L. No relevant disclosures or COIs. H.H. No relevant disclosures or COIs. M.St. No relevant disclosures or COIs. M.St. has received consulting fees from Neuroderm, Alexion, Biogen and Mediflix. D.W. No relevant disclosures or COIs. P.V. No relevant disclosures or COIs. A.W.W. No relevant disclosures or COIs. A.S. No relevant disclosures or COIs. S.X.X. No relevant disclosures or COIs. V.V.D. No relevant disclosures or COIs. A.S.C.P. No relevant disclosures or COIs. A.S.C.P. has received funding from the NIH, the Chan Zuckerberg Initiate Neurodegeneration Challenge, the AHA/Allen Institute Brain Health Initiative, and the Parker Family Chair. She also receives royalties from a patent relating to AAV-mediated approaches to treating frontotemporal dementia.
